Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

K

KLRS

Kalaris Therapeutics Inc

2.19

Oct 15 • 3:59 PM ET +0.06 (2.82%)

2.19

Aftermarket • 4:15 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Nano NASD

Peers: AARD CGTX CNTB KZIA NTHI SPRO VRCA AGEN GALT IMUX

| Held by: VTI VXF IWC BUSM DCOR DXUV DFAC

Index	-
Market Cap	47.83M
Enterprise Value	-44.31M
Income	-44.26M
Sales	0.00M
Book/sh	2.42
Cash/sh	4.28
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	20
IPO	Jul 30, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.90
P/C	0.51
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	10.92
Current Ratio	10.92
Debt/Eq	0.02
LT Debt/Eq	0.02
Option/Short	No / Yes

EPS (ttm)	-2.01
EPS next Y	-1.65
EPS next Q	-0.52
EPS this Y	29.78%
EPS next Y	17.43%
EPS next 5Y	5.48%
EPS past 3/5Y	61.69% 45.59%
Sales past 3/5Y	- -
EPS Y/Y TTM	73.44%
Sales Y/Y TTM	-
EPS Q/Q	20.27%
Sales Q/Q	-
Earnings	Aug 11 BMO
EPS/Sales Surpr.	3.03% -

Insider Own	63.69%
Insider Trans	1.79%
Inst Own	19.80%
Inst Trans	-2.22%
ROA	-46.02%
ROE	-79.91%
ROIC	-75.37%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-19.93%
SMA50	-35.60%
SMA200	-62.08%
Trades

Shs Outstand	23.80M
Shs Float	8.64M
Short Float	3.84%
Short Ratio	1.32
Short Interest	0.33M
52W High	11.88 -81.57%
52W Low	2.11 3.79%
Volatility	7.09% 6.80%
ATR (14)	0.19
RSI (14)	21.07
Beta	0.42
Rel Volume	0.23
Avg Volume	252.22K
Volume	56,980

Perf Week	-12.40%
Perf Month	-31.13%
Perf Quarter	-50.00%
Perf Half Y	-66.77%
Perf YTD	-74.05%
Perf Year	-55.58%
Perf 3Y	-94.46%
Perf 5Y	-99.57%
Perf 10Y	-
Recom	1.25
Target Price	18.71
Prev Close	2.13
Price	2.19
Change %	2.82%

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)